Exam Questions and Verified Answers |
Multiple Choice Test Bank with High-Yield
Study Solutions
• This 200-question Pharmacology 1 Final Exam covers core drug concepts tested in
2026, with verified answers and EXPERT RATIONALE designed to reinforce
understanding — not just memorization.
• Use this material by attempting each question first before checking the
highlighted correct answer and EXPERT RATIONALE below it for maximum
retention.
1. Which of the following best describes the term "pharmacokinetics"?
A. The study of drug mechanisms at receptor sites
B. The study of drug effects on the body
C. The study of how the body absorbs, distributes, metabolizes, and excretes drugs
D. The study of drug-drug interactions
E. The study of adverse drug reactions
C. The study of how the body absorbs, distributes, metabolizes, and
excretes drugs
EXPERT RATIONALE: Pharmacokinetics describes what the body does to a drug —
encompassing absorption, distribution, metabolism, and excretion (ADME).
Pharmacodynamics, in contrast, is what the drug does to the body.
2. Which route of drug administration has 100% bioavailability?
A. Oral
B. Sublingual
C. Intramuscular
,D. Intravenous
E. Transdermal
D. Intravenous
EXPERT RATIONALE: Intravenous (IV) administration delivers the drug directly into the
bloodstream, bypassing all absorption barriers, thus achieving 100% bioavailability.
3. The blood-brain barrier is primarily composed of which cell type?
A. Astrocytes
B. Microglia
C. Tight junctions of endothelial cells
D. Oligodendrocytes
E. Schwann cells
C. Tight junctions of endothelial cells
EXPERT RATIONALE: The BBB is formed by tight junctions between capillary endothelial
cells in the brain, restricting passage of many substances including large or hydrophilic
drugs.
4. Which of the following is the primary site of drug metabolism?
A. Kidneys
B. Lungs
C. Liver
D. Small intestine
E. Plasma
C. Liver
,EXPERT RATIONALE: The liver is the principal organ of drug metabolism, containing high
concentrations of cytochrome P450 enzymes responsible for biotransformation of most
drugs.
5. A drug that is a competitive antagonist will:
A. Permanently bind to and block a receptor
B. Activate a receptor to produce a submaximal response
C. Compete with agonists for the same receptor and its effect can be overcome by
increasing agonist concentration
D. Bind to an allosteric site to reduce receptor activity
E. Cause irreversible receptor downregulation
C. Compete with agonists for the same receptor and its effect can be
overcome by increasing agonist concentration
EXPERT RATIONALE: Competitive antagonists reversibly bind to the same site as the
agonist. Their effects are surmountable — increasing agonist concentration shifts the
dose-response curve to the right.
6. The volume of distribution (Vd) reflects:
A. The rate of drug clearance from the body
B. The extent of drug binding to plasma proteins
C. The apparent volume in which a drug is distributed throughout the body
D. The half-life of a drug
E. The fraction of drug absorbed after oral administration
C. The apparent volume in which a drug is distributed throughout the body
, EXPERT RATIONALE: Vd relates the total amount of drug in the body to plasma
concentration. A high Vd suggests extensive tissue distribution; a low Vd suggests the
drug remains in plasma.
7. Which cytochrome P450 enzyme is responsible for metabolizing the
majority of drugs?
A. CYP1A2
B. CYP2C9
C. CYP2D6
D. CYP3A4
E. CYP2E1
D. CYP3A4
EXPERT RATIONALE: CYP3A4 is the most abundant hepatic CYP enzyme and is
responsible for metabolizing approximately 50% of all clinically used drugs.
8. First-pass metabolism refers to:
A. Metabolism of a drug after IV administration
B. Drug degradation in the stomach due to gastric acid
C. Presystemic metabolism of a drug primarily in the gut wall and liver before
reaching systemic circulation
D. Renal excretion of unchanged drug
E. Metabolism of a drug by intestinal bacteria
C. Presystemic metabolism of a drug primarily in the gut wall and liver
before reaching systemic circulation